Login / Signup
Comments on: Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis.
Yan Wang
Xiu Sun
Junyan Zhang
Qi Mei
Published in:
Hepatology international (2024)
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
hepatitis b virus
peritoneal dialysis
prognostic factors
patient reported outcomes
antiretroviral therapy
liver fibrosis